Jonathan Heeney

New Capabilities

Leading the program into a planned Phase 2 trial

Vaccines have always chased the virus. You wait for a new strain, then design a shot to match it. A team at the University of Cambridge just tested a vaccine built the other way around: a machine-learning model designed its active ingredient to recognize a whole family of coronaviruses at once, including bat viruses that have never infected a person.

Updated Yesterday